Glutamine Breakdown as a Potential Metabolic Biomarker for Nonalcoholic Steatohepatitis

被引：1
|
作者：
Whitlock, Anna E. Garcia [1 ]
Titchenell, Paul M. [2 ]
机构：
[1] Univ Penn, Perelman Sch Med, Hosp Univ Penn, Dept Surg,Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Physiol, Inst Diabet Obes & Metab, Perelman Sch Med, Philadelphia, PA 19104 USA
来源：
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY | 2020年 / 10卷 / 01期
基金：
美国国家卫生研究院;
关键词：
FATTY LIVER-DISEASE; NAFLD;
D O I：
10.1016/j.jcmgh.2020.03.001
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：195 / 196
页数：2
相关论文
共 50 条
  • [1] The metabolic basis of nonalcoholic steatohepatitis
    Chakravarthy, Manu V.
    Neuschwander-Tetri, Brent A.
    [J]. ENDOCRINOLOGY DIABETES & METABOLISM, 2020, 3 (04)
  • [2] Nonalcoholic steatohepatitis and the metabolic syndrome
    Neuschwander-Tetri, BA
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2005, 330 (06): : 326 - 335
  • [3] New biomarker identified for nonalcoholic steatohepatitis
    Claire Greenhill
    [J]. Nature Reviews Gastroenterology & Hepatology, 2012, 9 (4) : 189 - 189
  • [4] An Apoptosis Biomarker for Prediction of Nonalcoholic Steatohepatitis
    Bantel, Heike
    Bahr, Matthias J.
    Schulze-Osthoff, Klaus
    [J]. HEPATOLOGY, 2009, 50 (03) : 991 - 991
  • [5] Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis
    Xu, Gang
    Wang, Yu-Min
    Ying, Miao-Miao
    Chen, Sui-Dan
    Li, Zong-Rui
    Ma, Hong-Lei
    Zheng, Ming-Hua
    Wu, Jian
    Ding, Chunming
    [J]. CLINICAL AND MOLECULAR HEPATOLOGY, 2021, 27 (02) : 329 - 345
  • [6] Nonalcoholic steatohepatitis: A composite of metabolic imbalances?
    Pinto, HC
    Camilo, ME
    Baptista, A
    Moura, MC
    [J]. HEPATOLOGY, 1997, 26 (04) : 1815 - 1815
  • [7] Evaluation of Metabolic Syndrome and Nonalcoholic Steatohepatitis
    Sertoglu, Erdim
    Uyanik, Metin
    Kayadibi, Huseyin
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2015, 49 (04) : 352 - 353
  • [8] MITOCHONDRIAL FERRITIN AS A BIOMARKER FOR THE DIAGNOSIS OF NONALCOHOLIC STEATOHEPATITIS
    Kawanaka, Miwa
    Hara, Yuichi
    Nishina, Sohji
    Nishinio, Ken
    Kawamoto, Hirofumi
    Hino, Keisuke
    [J]. HEPATOLOGY, 2021, 74 : 1117A - 1118A
  • [9] Serum Golgi Protein 73 as a Potential Biomarker for Hepatic Necroinflammation in Population with Nonalcoholic Steatohepatitis
    Wang, Leijie
    Yao, Mingjie
    Liu, Shuhong
    Yang, Danli
    Wen, Xiajie
    Ning, Jing
    Wang, Lu
    Zhou, Guangde
    Xu, Qiang
    Chen, Xiangmei
    Zhao, Jingmin
    Lu, Fengmin
    [J]. DISEASE MARKERS, 2020, 2020
  • [10] Nonalcoholic Steatohepatitis Is Frequently Accompanied by Metabolic Diseases
    Dogru, Teoman
    Ercin, Cemal Nuri
    Erdem, Gokhan
    Tasci, Ilker
    Sonmez, Alper
    Tapan, Serkan
    [J]. HEPATOLOGY, 2008, 48 (05) : 1728 - 1728
12345